Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026 A jump in 2026 earnings forecasts to 38% has brought institutional investors back into Russell 2000 stocks. Fed policy remains ...

While historical returns provide a useful starting point, they don’t tell the complete story. In this editorial, we discuss ...

The S&P/ASX Small Ordinaries Index (XSO) finished slightly weaker yesterday, slipping 5.30 points, or 0.15%, to 3,434.50.

Small-cap stocks posted a blistering performance in the first half of this year. The Russell 2000 Index surged 22% through June, marking its strongest first-half performance since ...

The Russell Microcap Index has more than doubled the performance of the S&P 500 this year . Microcap stocks as a group have soared this year. That comes with ...

Drug developers focusing on either disease area made up more than 40% of the number of biotech companies and amount raised so ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

Global merger activity reached a record $2.6 trillion in the first half of the year as companies pursued larger acquisitions, ...

The Russell 2000 has recently outperformed the S&P 500, and three factors are driving the move, according to Goldman Sachs. The small-cap stock index is up 20.5% since the start of the year and 37% ...

A caffeine giant, a growing CDMO business, and a recovering API segment. Can Aarti Pharmalabs convert a Rs 1,300+ crore capex ...

Imugene logs a second complete response within 24 hours in Azer-cel BTKi cohort, Day-28 CR in MCL after BTKi failure, ...

Small-cap stocks are on pace to notch their best first half of the year since 1991, and TD Cowen and Bank of America have ideas about how to play the trend.